4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-014257
EVP, Head of North America sold 3,020 shares at an average $57.03 ($172,238)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-12 | Sale 10b5-1 | −600 | $56.39 | $33,834 | 4,813 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-12 | Sale 10b5-1 | −10 | $56.41 | $564 | 4,803 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-12 | Sale 10b5-1 | −1,205 | $56.39 | $67,950 | 3,598 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2025-02-13 | Sale 10b5-1 | −1,205 | $58.00 | $69,890 | 2,393 | D |
| Open-market sales · 3,020 sh · avg $57.03 · $172,238 | |||||||
Loading xslF345X05/tm256729-1_4seq1.xml…